Brinkmann, Kerstin
Grabow, Stephanie http://orcid.org/0000-0003-0467-7871
Hyland, Craig D
Teh, Charis E
Alexander, Warren S
Herold, Marco J
Strasser, Andreas
Article History
Received: 18 March 2017
Revised: 14 June 2017
Accepted: 3 July 2017
First Online: 11 August 2017
Competing interests
: The authors collaborate with the pharmaceutical company Servier to develop MCL-1 inhibitors for cancer therapy. However, they have no financial interest in this drug development program.